
    
      This study is a prospective clinical study to demonstrate the safety and efficacy of the
      PicoWayTM device for tattoo removal.

      Up to a total of 60 healthy candidates who are seeking tattoo removal clearance treatment
      from participating investigators will be enrolled at up to 3 participating study sites.
      Subjects will receive up to eight (8) PicoWayTM treatments at 11±5 (6-16) week's intervals.
      Prior to each consecutive treatment, the investigator will decide, based on degree of
      clearance assessment, should the subject undergo additional treatment or to be forwarded to
      the 8 weeks Follow-Up visit with no more treatments. Topical anesthetic (ointment) or
      intradermal injected solution may be used prior to treatment.

      Each subject will be followed at one post treatment visit that will be conducted at:

      • Eight weeks post last treatment - 8wk FU.
    
  